Evidence map›Paper›PMID 32487148›Full record

ArticleMalaria journal2020

Estimating the risk of declining funding for malaria in Ghana: the case for continued investment in the malaria response.

Rima Shretta, Sheetal P Silal, Keziah Malm, Wahjib Mohammed, Joel Narh, Danielle Piccinini, Kathryn Bertram, Jessica Rockwood, Matt Lynch

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Mathematical assessment of the role of intervention programs for malaria control.medRxiv : the preprint server for health sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 5 countries.

Rima ShrettaJohns Hopkins Center for Communication Programs, 111 Market Pl Ste 310, Baltimore, MD, 21202, USA. rshretta@gmail.com.ORCID http://orcid.org/0000-0001-5011-5998
Sheetal P SilalCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Keziah MalmGhana National Malaria Control Programme, Ghana Health Service, Accra, Ghana.
Wahjib MohammedGhana National Malaria Control Programme, Ghana Health Service, Accra, Ghana.
Joel NarhGhana National Malaria Control Programme, Ghana Health Service, Accra, Ghana.
Danielle PiccininiJohns Hopkins Center for Communication Programs, 111 Market Pl Ste 310, Baltimore, MD, 21202, USA.
Kathryn BertramJohns Hopkins Center for Communication Programs, 111 Market Pl Ste 310, Baltimore, MD, 21202, USA.
Jessica RockwoodInternational Public Health Associates, Kensington, MD, USA.
Matt LynchJohns Hopkins Center for Communication Programs, 111 Market Pl Ste 310, Baltimore, MD, 21202, USA.
Johns Hopkins University · USGhana Health Service · GHUniversity of Cape Town · ZA

Funding

Wellcome Trust 214236Wellcome Trust 214236/Z/18/Z
6 · The paper itself

Abstract

backgroundGhana has made impressive progress against malaria, decreasing mortality and morbidity by over 50% between 2005 and 2015. These gains have been facilitated in part, due to increased financial commitment from government and donors. Total resources for malaria increased from less than USD 25 million in 2006 to over USD 100 million in 2011. However, the country still faces a high burden of disease and is at risk of declining external financing due to its strong economic growth and the consequential donor requirements for increased government contributions. The resulting financial gap will need to be met domestically. The purpose of this study was to provide economic evidence of the potential risks of withdrawing financing to shape an advocacy strategy for resource mobilization.

methodsA compartmental transmission model was developed to estimate the impact of a range of malaria interventions on the transmission of Plasmodium falciparum malaria between 2018 and 2030. The model projected scenarios of common interventions that allowed the attainment of elimination and those that predicted transmission if interventions were withheld. The outputs of this model were used to generate costs and economic benefits of each option.

resultsElimination was predicted using the package of interventions outlined in the national strategy, particularly increased net usage and improved case management. Malaria elimination in Ghana is predicted to cost USD 961 million between 2020 and 2029. Compared to the baseline, elimination is estimated to prevent 85.5 million cases, save 4468 lives, and avert USD 2.2 billion in health system expenditures. The economic gain was estimated at USD 32 billion in reduced health system expenditure, increased household prosperity and productivity gains. Through malaria elimination, Ghana can expect to see a 32-fold return on their investment. Reducing interventions, predicted an additional 38.2 clinical cases, 2500 deaths and additional economic losses of USD 14.1 billion.

conclusionsMalaria elimination provides robust epidemiological and economic benefits, however, sustained financing is need to accelerate the gains in Ghana. Although government financing has increased in the past decade, the amount is less than 25% of the total malaria financing. The evidence generated by this study can be used to develop a robust domestic strategy to overcome the financial barriers to achieving malaria elimination in Ghana.

Indexed as

Communicable Disease ControlFinancing, GovernmentGhanaHealth ExpendituresInvestmentsMalaria, FalciparumModels, TheoreticalBenefitsCostsEconomicFinancingFundingGhanaInvestment caseMalaria

Identifiers

PMID32487148
PMCPMC7268595
OpenAlexW3029969312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.